Sharon DeMorrow Selected Research

ATP-Binding Cassette Sub-Family B Member 4

1/2022	Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis.
1/2020	Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
11/2017	Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharon DeMorrow Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 04/2007
19	Cholangiocarcinoma 01/2018 - 04/2007
18	Hepatic Encephalopathy 01/2022 - 03/2011
17	Fibrosis (Cirrhosis) 01/2022 - 02/2008
14	Liver Diseases (Liver Disease) 01/2021 - 10/2007
13	Hyperplasia 01/2022 - 05/2007
12	Cholestasis 01/2022 - 09/2007
10	Inflammation (Inflammations) 01/2022 - 12/2016
9	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 08/2015
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 11/2014
7	Neuroinflammatory Diseases 12/2019 - 01/2016
4	Liver Failure 06/2021 - 12/2014
2	Obesity 01/2022 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2008
2	Nervous System Diseases (Neurological Disorders) 08/2020 - 11/2016
2	Necrosis 01/2019 - 08/2011
2	Carcinogenesis 01/2018 - 08/2008
2	Body Weight (Weight, Body) 01/2018 - 08/2009
2	Brain Edema (Cerebral Edema) 01/2018 - 08/2015
2	Fatty Liver 01/2018 - 04/2017
2	Sclerosing Cholangitis 10/2017 - 10/2016
2	Disease Progression 01/2017 - 11/2015
2	Neurologic Manifestations (Neurological Manifestations) 12/2016 - 12/2014
1	Hyperammonemia 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Hypoxia (Hypoxemia) 01/2021

Drug/Important Bio-Agent (IBA)

13	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 06/2014
9	AzoxymethaneIBA 01/2020 - 07/2014
7	EnzymesIBA 01/2021 - 11/2008
7	Histamine (Histamine Dihydrochloride)FDA Link 11/2018 - 05/2012
6	EndocannabinoidsIBA 07/2011 - 04/2007
4	CytokinesIBA 01/2022 - 07/2014
4	AmmoniaIBA 01/2022 - 01/2017
4	CollagenIBA 11/2017 - 08/2011
4	NeuropeptidesIBA 04/2017 - 09/2007
4	anandamide (arachidonylethanolamide)IBA 07/2011 - 04/2007
3	Neutralizing AntibodiesIBA 01/2022 - 05/2011
3	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2022 - 11/2017
3	LeptinIBA 01/2022 - 08/2008
3	Transaminases (Aminotransferases)IBA 01/2020 - 08/2011
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2019 - 10/2016
3	Histamine Receptors (Histamine Receptor)IBA 01/2018 - 10/2009
3	MelatoninIBA 11/2017 - 11/2014
3	Hormones (Hormone)IBA 11/2017 - 07/2008
3	Histidine DecarboxylaseIBA 10/2016 - 05/2012
3	Secretin FDA Link 11/2014 - 07/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 10/2009
3	Monoamine Oxidase (MAO)IBA 10/2012 - 11/2008
3	Serotonin (5 Hydroxytryptamine)IBA 10/2012 - 11/2008
3	Messenger RNA (mRNA)IBA 08/2011 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 05/2011 - 05/2007
2	Leptin ReceptorsIBA 01/2022 - 08/2008
2	NitrogenIBA 01/2021 - 12/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 12/2014
2	ChemokinesIBA 10/2019 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 01/2018
2	Thioacetamide (Thioacetamid)IBA 01/2018 - 08/2008
2	Carboxy-LyasesIBA 01/2018 - 01/2018
2	Histidine (L-Histidine)FDA Link 01/2018 - 01/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2017 - 04/2015
2	Arylalkylamine N-AcetyltransferaseIBA 10/2017 - 11/2014
2	MorpholinosIBA 04/2017 - 12/2014
2	salicylhydroxamic acid (SHAM)IBA 04/2017 - 08/2011
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2017 - 08/2009
2	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2017 - 02/2016
2	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 10/2016 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 02/2016 - 09/2010
2	Peptides (Polypeptides)IBA 12/2015 - 04/2015
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2014 - 08/2011
2	Substance PIBA 05/2014 - 08/2011
2	Neuropeptide YIBA 08/2013 - 05/2011
2	Adenosine (Adenocard)FDA LinkGeneric 03/2013 - 05/2007
2	secretin receptorIBA 03/2013 - 07/2010
2	Dopamine (Intropin)FDA LinkGeneric 10/2012 - 05/2010
2	MicroRNAs (MicroRNA)IBA 01/2012 - 12/2007
2	LipidsIBA 07/2011 - 04/2007
2	Death Domain ReceptorsIBA 07/2011 - 04/2007
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 05/2010 - 04/2007
1	Taurine FDA Link 06/2021
1	CytochromesIBA 01/2021
1	interleukin-24 (ST16)IBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 05/2020
1	Pharmaceutical PreparationsIBA 05/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Thrombospondin 1IBA 01/2020
1	Ghrelin ReceptorsIBA 01/2020
1	Galanin Receptors (Galanin Receptor)IBA 01/2020
1	GhrelinIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 12/2019
1	Interleukin-8 (Interleukin 8)IBA 10/2019
1	CCR2 ReceptorsIBA 10/2019

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2007
3	Ligation 04/2017 - 07/2010
3	Drug Therapy (Chemotherapy) 09/2010 - 11/2008
2	Aftercare (After-Treatment) 11/2018 - 05/2011
2	Radiotherapy 05/2010 - 11/2008